Back to discover
Disease

Granulomatous Mastitis

Clinical development underwayEmerging research
1
Publications
4
Clinical trials
2024
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Clinical trials

1 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
4
All trials
0
Active
0
Late-stage
1
Completed

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Major themes2
  • Erythema Nodosum1
  • Granulomatous Mastitis1
Leading journals1
  • Frontiers in immunology1
Leading researchers7
  • He X1
  • Liu J1
  • Luo J1
  • Wan H1
  • Wang X1
  • Yang J1
  • Zhang H1
Affiliations (unnormalised)5
  • Breast Center1
  • Clinical Research Center for Breast1
  • Laboratory of Tumor Targeted and Immune Therapy1
  • Sichuan Provincial Maternity and Child Health Care Hospital1
  • West China School of Medicine/West China Hospital1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

A rare, benign, inflammatory breast disease occurring in premenopausal women shortly after a recent pregnancy. The origin is unknown but it is commonly mistaken for malignancy and sometimes associated with BREAST FEEDING and the use of ORAL CONTRACEPTIVES.

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.